John S. Major

741 total citations
27 papers, 578 citations indexed

About

John S. Major is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John S. Major has authored 27 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John S. Major's work include Receptor Mechanisms and Signaling (6 papers), Renin-Angiotensin System Studies (6 papers) and Synthesis and Biological Evaluation (6 papers). John S. Major is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Renin-Angiotensin System Studies (6 papers) and Synthesis and Biological Evaluation (6 papers). John S. Major collaborates with scholars based in United Kingdom, United States and India. John S. Major's co-authors include P. Scholes, Robert H. Bradbury, Arnold H. Ratcliffe, Brian B. Masek, P. J. Heald, Michael Robert Dennis, Dave J. Hayes, Gérard Mathis, David A. Roberts and Young-Whan Park and has published in prestigious journals such as Journal of Medicinal Chemistry, Drug Discovery Today and Reproduction.

In The Last Decade

John S. Major

27 papers receiving 526 citations

Peers

John S. Major
David H. Singleton United States
Ligaya M. Simpkins United States
Jih‐Lie Tseng United States
Wolfgang Wostl Switzerland
Elfatih Elzein United States
M. Ohno Japan
Névéna Mollova United States
Sharon Rossiter United Kingdom
Esther Marco Spain
Jean‐Pierre Gotteland United States
David H. Singleton United States
John S. Major
Citations per year, relative to John S. Major John S. Major (= 1×) peers David H. Singleton

Countries citing papers authored by John S. Major

Since Specialization
Citations

This map shows the geographic impact of John S. Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Major more than expected).

Fields of papers citing papers by John S. Major

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Major. The network helps show where John S. Major may publish in the future.

Co-authorship network of co-authors of John S. Major

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Major. A scholar is included among the top collaborators of John S. Major based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Major. John S. Major is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kopáni, Martin, et al.. (2018). Iron deposition in rabbit cerebellum after exposure to generated and mobile GSM electromagnetic fields. Bratislavské lekárske listy/Bratislava medical journal. 118(10). 575–579. 17 indexed citations
2.
Allen, Joanne V., Catherine Bardelle, Kevin Blades, et al.. (2011). The discovery of benzanilides as c-Met receptor tyrosine kinase inhibitors by a directed screening approach. Bioorganic & Medicinal Chemistry Letters. 21(18). 5224–5229. 9 indexed citations
3.
Major, John S.. (1999). What is the Future of High Throughput Screening?. SLAS DISCOVERY. 4(3). 119–119. 4 indexed citations
4.
Major, John S.. (1998). Challenges and Opportunities in High Throughput Screening: Implications for New Technologies. SLAS DISCOVERY. 3(1). 13–17. 38 indexed citations
5.
Kaplita, Paul V., et al.. (1998). Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence. Drug Discovery Today. 3(7). 333–342. 68 indexed citations
6.
Major, John S.. (1995). Minireview: Challenges of High Throughput Screening Against Cell Surface Receptors. Journal of Receptors and Signal Transduction. 15(1-4). 595–607. 16 indexed citations
7.
8.
9.
Bradbury, Robert H., Michael Robert Dennis, Eric F. Fisher, et al.. (1993). Quinoline, 1,5-naphthyridine and pyridine derivatives as potent, nonpeptidic angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 3(5). 899–904. 8 indexed citations
10.
Thomas, Andrew P., Keith H. Gibson, John S. Major, et al.. (1992). New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives. Journal of Medicinal Chemistry. 35(5). 877–885. 81 indexed citations
11.
12.
Schaff, Z, K. Lapis, B. Szende, et al.. (1991). The effect of D-penicillamine on CCl4-induced experimental fiver cirrhosis. Experimental Pathology. 43(1-2). 111–120. 10 indexed citations
13.
Roberts, D. Allen, Robert H. Bradbury, David Brown, et al.. (1990). 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives. Journal of Medicinal Chemistry. 33(9). 2326–2334. 7 indexed citations
14.
Bradbury, Robert H., John S. Major, David A. Roberts, et al.. (1990). 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives. Journal of Medicinal Chemistry. 33(9). 2335–2342. 12 indexed citations
15.
Dutta, Anand S., et al.. (1990). Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp. Journal of Medicinal Chemistry. 33(9). 2552–2560. 8 indexed citations
16.
Dutta, Anand S., et al.. (1990). Inhibitors of human renin. Cyclic peptide analogs containing a D-Phe-Lys-D-Trp sequence. Journal of Medicinal Chemistry. 33(9). 2560–2568. 6 indexed citations
17.
Samani, Nilesh J., et al.. (1989). Kidney renin mRNA levels in the early and chronic phases of two-kidney, one clip hypertension in the rat. Journal of Hypertension. 7(2). 105???112–105???112. 39 indexed citations
18.
Major, John S., et al.. (1984). In Vivo Comparison of the Renin Inhibitor H77 with the Angiotensin-Converting Enzyme Inhibitor Captopril. Journal of Cardiovascular Pharmacology. 6(4). 672–677. 16 indexed citations
19.
Major, John S., et al.. (1976). INTERACTIONS OF OESTRADIOL-17β AND TAMOXIFEN IN THE UTERUS OF THE PREGNANT RAT. Journal of Endocrinology. 71(3). 315–324. 15 indexed citations
20.
Major, John S. & P. J. Heald. (1974). THE EFFECTS OF ICI 46,474 ON OVUM TRANSPORT AND IMPLANTATION IN THE RAT. Reproduction. 36(1). 117–124. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David H. Singleton Breakdown of academic impact, for papers by Ligaya M. Simpkins Breakdown of academic impact, for papers by Jih‐Lie Tseng Breakdown of academic impact, for papers by Wolfgang Wostl Breakdown of academic impact, for papers by Elfatih Elzein Breakdown of academic impact, for papers by M. Ohno Breakdown of academic impact, for papers by Névéna Mollova Breakdown of academic impact, for papers by Sharon Rossiter Breakdown of academic impact, for papers by Esther Marco Breakdown of academic impact, for papers by Jean‐Pierre Gotteland
Rankless by CCL
2026